Insider trades
Venker Eric, CEO of Roivant Sciences ROIV, has filed 0 purchases and 78 sales on the open market. Over the past 12 months that comes to a net sale of $76M. The latest trade was on 06/24.
Venker Eric
President & Immunovant CEO
- Company
- Roivant Sciences ROIV
- First filing
- 23/01/26
- Trades
- 274 trades
- Buys / sales
- 0 / 78
- 12-month net buying
- −$76M
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ROIV | Open-market sale10b5-1 plan | 06/24 | 06/26 | 200,000 sh2 trades | $33.16avg. | $6,631,267.64 | −11.0% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 05/22 | 05/22 | 200,000 sh | $30.27 | $6,054,000 | −11.0% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 04/20 | 04/22 | 200,000 sh | $29.59 | $5,918,000 | −10.8% |
IMVT | Open-market sale | 04/02 | 04/03 | 14,229 sh2 trades | $24.10avg. | $342,854.2 | −42.1% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 03/17 | 03/19 | 200,000 sh | $28.24 | $5,648,000 | −10.8% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 02/13 | 02/18 | 200,000 sh | $26.49 | $5,298,000 | −10.8% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 01/12 | 01/14 | 200,000 sh | $21.92 | $4,384,000 | −10.8% |
ROIV | Open-market sale | 25/12/23–25/12/24 | 25/12/29 | 275,000 sh2 trades | $22.47avg. | $6,179,750 | −14.3% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/12/09 | 25/12/11 | 200,000 sh | $20.85 | $4,170,000 | −11.8% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/11/07 | 25/11/07 | 200,000 sh | $20.22 | $4,044,000 | −11.7% |
ROIV | Open-market sale10b5-1 plan | 25/10/15–25/10/17 | 25/10/17 | 851,383 sh3 trades | $16.99avg. | $14,467,502.37 | −36.1% |
ROIV | Open-market sale10b5-1 plan | 25/10/09–25/10/13 | 25/10/14 | 125,667 sh2 trades | $16.29avg. | $2,047,335.75 | −7.7% |
ROIV | Open-market sale10b5-1 plan | 25/10/06–25/10/08 | 25/10/08 | 665,159 sh3 trades | $16.21avg. | $10,781,813.19 | −30.7% |
ROIV | Open-market sale10b5-1 plan | 25/09/19–25/09/23 | 25/09/23 | 1,711,000 sh4 trades | $14.92avg. | $25,524,777.28 | −53.2% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/08/20 | 25/08/22 | 100,000 sh | $11.72 | $1,172,000 | −5.7% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/07/21 | 25/07/23 | 100,000 sh | $11.52 | $1,152,000 | −6.4% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/06/20 | 25/06/24 | 100,000 sh | $11.45 | $1,145,000 | −6.4% |
ROIV | Open-market sale | 25/06/02–25/06/03 | 25/06/04 | 1,000,000 sh2 trades | $11.15avg. | $11,154,941.7 | −40.6% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/05/20 | 25/05/22 | 100,000 sh | $10.95 | $1,095,000 | −8.5% |
Roivant SciencesROIV | Open-market sale10b5-1 plan | 25/04/21 | 25/04/22 | 100,000 sh | $10.22 | $1,022,000 | −8.2% |
